Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

'Pharmacist only' medicines.

T L Bessell1, J E Hiller, L N Sansom

  • 1Department of Public Health, University of Adelaide, South Australia. tracey_bessell@msn.com.au

Australian and New Zealand Journal of Public Health
|January 21, 2000
PubMed
Summary
This summary is machine-generated.

Australia

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.

Familial cancer·2020
Same author

The effects of ambient temperature and heatwaves on daily Campylobacter cases in Adelaide, Australia, 1990-2012.

Epidemiology and infection·2017
Same author

The effect of temperature on different Salmonella serotypes during warm seasons in a Mediterranean climate city, Adelaide, Australia.

Epidemiology and infection·2015
Same author

Undiagnosed hypertension in a rural district in Bangladesh: The Bangladesh Population-based Diabetes and Eye Study (BPDES).

Journal of human hypertension·2015
Same author

Does Co-morbidity provide significant improvement on age adjustment when predicting medical outcomes?

Methods of information in medicine·2014
Same author

A systematic review of surgical biopsy for LCIS found at core needle biopsy - do we have the answer yet?

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2013
Same journal

The costs of diagnosing and treating skin cancer: Findings from the QSkin Study.

Australian and New Zealand journal of public health·2026
Same journal

Australians' experiences with vaping after the implementation of vape reforms: A qualitative study.

Australian and New Zealand journal of public health·2026
Same journal

What's in the Box? Analysis of the nutritional content and adoption of Health Star Ratings among packaged lunchbox snacks released in Australia: 2013-2024.

Australian and New Zealand journal of public health·2026
Same journal

Public Health at Risk: Insights from the 2026 Communicable Disease and Immunisation Conference.

Australian and New Zealand journal of public health·2026
Same journal

The potential for adverse events or harms are not routinely assessed or reported in evaluations of public health interventions.

Australian and New Zealand journal of public health·2026
Same journal

Social connection: The new frontier for better health in 2026.

Australian and New Zealand journal of public health·2026
See all related articles

Area of Science:

  • Pharmacovigilance
  • Public Health Policy
  • Pharmaceutical Access

Background:

  • Global trend towards non-prescription medicines.
  • Australia's unique 'pharmacist only medicines' (POM) schedule.
  • Lack of evaluation on the impact of POM.

Purpose of the Study:

  • Evaluate the impact of pharmacist only medicines (POM).
  • Discuss public health concerns related to POM.
  • Examine antifungal vaginal products as a case study.

Main Methods:

  • Qualitative discussion of public health concerns.
  • Analysis of consumer choice and control in healthcare.
  • Review of existing literature and policy.

Main Results:

  • Pharmacist only medicines (POM) offer potential consumer benefits.
  • Significant public health concerns exist regarding POM.
  • No current data available on POM use or impact.

Conclusions:

  • Recommendations for legislative changes and data collection.
  • Need for improved information provision on POM.
  • Importance of quality use of medicines and partnerships.